Inflammatory Bowel Disease Treatment Market Projected to Reach 3670 Million at 3.66% CAGR Till 2022 : Global Key Players – Abbott Laboratories, Valeant Pharmaceuticals In
The market report “Global Inflammatory Bowel Disease Treatment Market 2018” offers vital insights on every market segment in terms of market size analysis for Industry across the different regions.
Pune, India -- (SBWire) -- 09/14/2018 --Global Inflammatory Bowel Disease Treatment Market -Highlights
The inflammatory bowel disease treatment market is expected to register a CAGR of 2.5% during the forecast period due to the increasing patient pool, advances in medical technology, and government initiatives for research on novel drugs discovery, and increasing prevalence of anxiety and depression.
Moreover, the increasing number of drugs in clinical trials and the growing popularity of prebiotic and probiotic foods are likely to result in market growth. However, high capital investments required for the discovery of drugs, the unsatisfactory effectiveness of treatments, and stringent drug regulatory policies are restraining the growth of the inflammatory bowel disease treatment market.
Try Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/6266
Global Inflammatory Bowel Disease Treatment Market -Key Players
Market Research Future (MRFR) recognizes
Abbott Laboratories
Valeant Pharmaceuticals International
Novartis AG
Janssen Biotech, Inc.
Alkem Laboratories Limited
AbbVie, Inc.
UCB Inc
Takeda Pharmaceutical Company Limited
Biogen Inc.
Pfizer Inc.
Allergan plc
As the key players in the global inflammatory bowel disease treatment market.
Global Inflammatory Bowel Disease Treatment Market -Regional Analysis
The Americas is expected to be the largest market for inflammatory bowel disease treatment owing to the increasing prevalence of anxiety and rising incidences of ulcerative colitis and Crohn's disease.
The Centers for Disease Control and Prevention (CDC) has stated that about 1.3% of US adults (3 million) were diagnosed with IBD, either Crohn's disease or ulcerative colitis, in 2015.
Europe was the second-largest market for inflammatory bowel disease treatment in 2017 and is expected to register a steady growth rate during the forecast period.
Asia-Pacific is expected to be the fastest-growing inflammatory bowel disease treatment market due to the exponential rise in patient population.
The market in the Middle East & Africa is expected to grow at the slowest rate due to the lack of awareness about the disease, limited access to and availability of treatment facilities, and the prevalence of inflammatory bowel disease.
Global Inflammatory Bowel Disease Treatment Market-Segmentation
The global inflammatory bowel disease treatment market has been segmented on the basis of drug class, disease indication, distribution channel, and end-user.
Based on drug class, the market has been segmented into TNF inhibitors, aminosalicylates, immunomodulators, and corticosteroids.By disease indication, the market has been segmented into ulcerative colitis and Crohn's disease.
Based on distribution channel, the market has been segmented into hospital pharmacy, retail pharmacy, and online pharmacy. By end-user, the market has been segmented into hospitals and clinics and others.
Based on region, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The market in the Americas has been further segmented into North America and South America. The European market has been further divided into Western Europe and Eastern Europe
Major Points form Table of Content of Global Inflammatory Bowel Disease Treatment Market
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Inflammatory Bowel Disease Treatment Market, By Type
Chapter 7. Global Inflammatory Bowel Disease Treatment Market, By Treatment
Chapter 8 Global Inflammatory Bowel Disease Treatment Market, By End User
Chapter 9. Global Inflammatory Bowel Disease Treatment Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
Avail Attractive Discount @ https://www.marketresearchfuture.com/check-discount/6266
About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Media Relations Contact
Market Research Future
Executive
646-845-9312
https://www.marketresearchfuture.com/reports/in-flight-entertainment-market-5808
View this press release online at: http://rwire.com/1047956